AptaBio Therapeutics Inc. (293780.KQ)

KRW 6500.0

(-3.56%)

Total Debt Summary of AptaBio Therapeutics Inc.

  • AptaBio Therapeutics Inc.'s latest annual total debt in 2023 was 13.93 Billion KRW , up 3706.77% from previous year.
  • AptaBio Therapeutics Inc.'s latest quarterly total debt in 2024 Q2 was 15.78 Billion KRW , up 6.59% from previous quarter.
  • AptaBio Therapeutics Inc. reported annual total debt of 366.03 Million KRW in 2022, up 261.19% from previous year.
  • AptaBio Therapeutics Inc. reported annual total debt of 101.34 Million KRW in 2021, up 65.85% from previous year.
  • AptaBio Therapeutics Inc. reported quarterly total debt of 14.8 Billion KRW for 2024 Q1, up 6.25% from previous quarter.
  • AptaBio Therapeutics Inc. reported quarterly total debt of 16.99 Billion KRW for 2023 Q3, up 4313.86% from previous quarter.

Annual Total Debt Chart of AptaBio Therapeutics Inc. (2023 - 2016)

Historical Annual Total Debt of AptaBio Therapeutics Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 13.93 Billion KRW 3706.77%
2022 366.03 Million KRW 261.19%
2021 101.34 Million KRW 65.85%
2020 61.1 Million KRW -29.34%
2019 86.48 Million KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%

Peer Total Debt Comparison of AptaBio Therapeutics Inc.

Name Total Debt Total Debt Difference
HLB Pharmaceutical Co., Ltd 23.72 Billion KRW 41.275%
CMG Pharmaceutical Co., Ltd. 19.74 Billion KRW 29.424%
Celltrion Pharm, Inc. 162.52 Billion KRW 91.427%
Huons Global Co., Ltd. 254.93 Billion KRW 94.534%
DongKook Pharmaceutical Co., Ltd. 104.74 Billion KRW 86.697%
Enzychem Lifesciences Corporation 5.65 Billion KRW -146.316%
Humedix Co., Ltd. 2.7 Billion KRW -415.743%
Boditech Med Inc. 10.56 Billion KRW -31.853%
EuBiologics Co., Ltd. 14.77 Billion KRW 5.716%
FutureChem Co.,Ltd 3.68 Billion KRW -278.382%
Huons Co., Ltd. 124.61 Billion KRW 88.818%
BNC Korea Co., Ltd. 737.2 Million KRW -1790.117%